Shawn Carbonell, MD, PhD, Cofounder and Managing Partner of Brazen Capital. He is a graduate of the University of Virginia Medical Scientist Training Program and completed postdocs at Oxford University and UCSF.

After a major discovery in brain cancer, Dr. Carbonell quit neurosurgery residency to cofound his first biotech startup, OncoSynergy, Inc. He raised over $20M in dilutive and non-dilutive funding and led the development of the first-in-class therapeutic he invented, OS2966.

Today, his mission is to help founders overcome the tremendous obstacles that are unique to this industry — obstacles that he personally faced when starting his first company. He sees great value in encouraging more scientists to become CEOs to launch novel technologies to advance human health.

PS: he is also addicted to pickleball and runs operations for The New Jersey 5s professional pickleball team.